בשל "הגנת זכויות יוצרים", מובא להלן קישור למאמר בלבד. לקריאתו בטקסט מלא, אנא פנה לספרייה הרפואית הזמינה לך.

Anesthetic care of infants and children has evolved considerably over the last four decades.

In the mid-1980s, infants were undergoing invasive procedures with either no or “light” anesthesia supplemented with a neuromuscular blocking agent. Parents became appalled, which motivated a public outcry and sparked an intense discussion among anesthesia providers on how best to anesthetize infants.

This led to a paradigm shift in pediatric anesthesiology, with providers recognizing the possibility and consequences of pain in infants undergoing surgery and reconsidering anesthetic regimens accordingly.

The pendulum has now swung in the opposite direction, as the conversation in pediatric anesthesia over the last decade has been dominated by neurotoxicity and the potentially detrimental effects of anesthetics in the developing brain, brought into public view by a recent Food and Drug Administration black box warning on anesthetic medications for young children and pregnant women.